Effect of Obesity, Dyslipidemia, and Diabetes on Trastuzumab-related Cardiotoxicity in Breast Cancer
Pauline K. Kosalka(NOSM University), O. Aseyev(McMaster University), Christopher Johnson(University of Ottawa), Angeline Law(University of Ottawa), Susan Dent(Washington Hospital), Jeffrey Sulpher(BC Cancer Agency), J. Botros(University of Ottawa), Michèle Turek(Ottawa Hospital)
Cited by 37
Related Papers
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k
Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes
|JAMA Oncology|2016|375
Combined Angioplasty and Pharmacological Intervention Versus Thrombolysis Alone in Acute Myocardial Infarction (CAPITAL AMI Study)
|Journal of the American College of Cardiology|2005|254
Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy
|Canadian Journal of Cardiology|2016|234
Shared Risk Factors for Cardiovascular Disease and Cancer: Implications for Preventive Health and Clinical Care in Oncology Patients
|Canadian Journal of Cardiology|2016|173